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Abstract
Objectives Obtain summary estimates of sensitivity and spec-
ificity for imaging modalities for chronic pancreatitis (CP)
assessment.
Methods A systematic search was performed in Cochrane
Library, MEDLINE, Embase and CINAHL databases for
studies evaluating imaging modalities for the diagnosis of
CP up to September 2016. A bivariate random-effects model-
ing was used to obtain summary estimates of sensitivity and
specificity.
Results We included 43 studies evaluating 3460 patients.
Sensitivity of endoscopic retrograde cholangiopancreatography
(ERCP) (82%; 95%CI: 76%-87%) was significant higher than
that of abdominal ultrasonography (US) (67%; 95%CI: 53%-
78%; P=0.018). The sensitivity estimates of endoscopic ultraso-
nography (EUS), magnetic resonance imaging (MRI), and com-
puted tomography (CT) were 81% (95%CI: 70%-89%), 78%
(95%CI: 69%-85%), and 75% (95%CI: 66%-83%), respective-
ly, and did not differ significantly from each other. Estimates of
specificity were comparable for EUS (90%; 95%CI: 82%-95%),
ERCP (94%; 95%CI: 87%-98%), CT (91%; 95% CI: 81%-
96%), MRI (96%; 95%CI: 90%-98%), and US (98%; 95%CI:
89%-100%).
Conclusions EUS, ERCP, MRI and CT all have comparable
high diagnostic accuracy in the initial diagnosis of CP. EUS
and ERCP are outperformers and US has the lowest accuracy.
The choice of imaging modality can therefore be made based
on invasiveness, local availability, experience and costs.
Key Points
• EUS, ERCP, MRI and CT have high diagnostic sensitivity for
chronic pancreatitis
• Diagnostic specificity is comparable for all imaging
modalities
• EUS and ERCP are outperformers and US has the lowest
accuracy
• The choice of imaging can be made based on clinical
considerations
Keywords Chronic pancreatitis . Diagnostic imaging .
Diagnostic accuracy .Meta-analysis
Introduction
Chronic pancreatitis (CP) is a disabling inflammatory disease
of the pancreas characterized by severe recurrent or continu-
ous abdominal pain and considerable impact on the quality of
life [1–4]. Patients with CP usually develop endocrine and
exocrine insufficiency during the course of the disease as a
result of the progressive loss of pancreatic parenchyma.
There is lack of international consensus regarding the ini-
tial diagnosis of CP, particularly at its early stages. The diag-
nosis is often made by a combination of clinical symptoms
(e.g. abdominal pain, malabsorption, diabetes mellitus), pan-
creatic function tests (e.g. fecal elastase-1) and morphological
abnormalities seen on imaging (e.g. calcifications, ductal le-
sions, pseudocysts) [5, 6]. Imaging plays a key role in the
diagnosis and therapeutic management of patients with CP.
The most frequently used imaging modalities for CP are en-
doscopic ultrasonography (EUS), endoscopic retrograde
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cholangiopancreatography (ERCP), magnetic resonance im-
aging (MRI), computed tomography (CT) and ultrasonogra-
phy (US).
The aim of this meta-analysis was to determine the diag-




A search was performed in Cochrane Library, MEDLINE,
EMBASE and CINAHL databases, without restrictions for
publication date or language up to September 2016. The
search included terms for chronic pancreatitis, EUS, ERCP,
MR imaging, CT and US. For detailed search details, see
Appendix Table 5.
Selection of studies
All search hits were screened on title and abstract and eligible
articles on full text by two reviewers independently (YI and
MAK). Disagreements were solved through discussion with a
third reviewer (MAB). Studies were eligible when EUS,
ERCP, MR imaging, CTor US was evaluated in patients with
suspected CP. Duplicates, reviews, letters, case reports and
book chapters were excluded. The remaining studies were
potentially eligible and their full text was retrieved. To identify
additional relevant studies, the reference lists of the included
studies were checked manually. Studies were included if they
met the following criteria: (1) sufficient data was reported to
construct 2 × 2 tables (true positive, false positive, true nega-
tive and false negative); (2) the imaging technique was com-
pared with a reference standard (e.g. surgery, histology, fol-
low-up). Exclusion criteria were: (1) evaluation of imaging
techniques other than the aforementioned (e.g. PET-CT,
EUS-FNA, EUS-elastography); (2) imaging techniques used
for treatment of patients with CP (e.g. therapeutic ERCP,
EUS-guided pseudocyst drainage); (3) in vitro studies; (4)
studies that included less than five patients with CP; (5) stud-
ies where no separate analysis were done for patients with CP;
and (6) full-text articles that were not available or retrievable.
Data extraction and critical appraisal
Data was extracted systematically from the included studies
by using a structured study record form. The following study
design and patient characteristics were extracted: name of the
first author, country of origin, year of publication, name of
journal, study design, total number of patients included, num-
ber of included patients with CP, median or mean age, the
proportion of male patients, and the patient inclusion criteria.
Data was extracted regarding the imaging characteristics:
type of imaging modality, scoring criteria, technical features
for eachmodality, and reported observer experience. Also data
on the reference standard was extracted, such as clinical fol-
low-up, surgery and histology.
The methodological quality of the included articles
was assessed by the Quality Assessment of Diagnostic
Accuracy Studies version 2 (QUADAS-2) tool [7]. The
QUADAS-2 tool evaluates the risk of bias in four do-
mains (patient selection, index test, reference standard,
flow and timing) and the clinical applicability in the
first three domains. Signaling questions were used to
help assess the risk of bias and applicability. Possible
answers were ‘yes’, ‘no’ or ‘unclear’ in which ‘yes’
indicates no risk of bias. In addition the GRADE scor-
ing system for diagnostic tests was used, which assesses
the quality of evidence for each imaging modality [8,
9]. Although the criteria are applicable to diagnostic test
accuracy, the methods are less well established com-
pared to interventional studies [10]. Two reviewers in-
dependently (YI and MAK) assessed the QUADAS-2
and the GRADE scoring system and all disagreements
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Excluded on full-text N=234 
Reason for exclusion:  
- Article not available (n=5) 
- Different patient group (n=37) 
- In vitro (n=1) 
- Insufficient data  (n=92) 
- Lack of reference standard (n=15) 
- Less than 5 patients (n=4) 
- Only data on sensitivity  (n=33) 
- Other disease (n=14) 
- Other imaging modality (n=11) 
- Other type of article (n=22) 




For each included study we constructed a 2 × 2 contingency
table for each imaging modality. If diagnostic accuracy was
compared between different observers, mean values were
calculated. Sensitivity and specificity estimates, the positive
predictive value and negative predictive values, and the accu-
racy were calculated from the reconstructed contingency ta-
bles. We used the I2 test with 95% confidence interval (95%
CI) to quantify heterogeneity [11]. Mean logit sensitivity and
specificity were acquired, and the anti-logit transformation
was then obtained to calculate summary estimates of
Table 1 Study characteristics of included studies
Study Year Country P/R OE Modality Reference standard for CP diagnosis
Adamek et al 2000 Germany P No MRCP/ERCP Histology (NA), FU (NA)
Albashir et al 2010 USA R Yes EUS Histology (all)
Alcaraz et al 2000 Spain P Yes MRCP Surgery (4), ERCP (70), PTC (7)
Balci et al 2006 USA and Germany R No MRCP ePFT (all)
Bolog et al 2004 Romania R No MRCP Surgery (NA), ERCP (NA), FU (NA)
Brand et al 2000 Germany P No EUS Histology (all)
Buscail et al 1995 France P No US/CT/ERCP
/EUS
Histology (7), morphological
changes (i.e. calcifications) and
exocrine insufficiency (42) + FU (all)
Catalano et al 1998 USA P No EUS ERCP + ePFT (all)
Chong et al 2007 USA R Yes EUS Surgery (all)
Conwell et al 2007 USA R Yes EUS ePFT (all)
Dramaix et al 1980 France P No US/CT Surgery (NA), ERCP (NA)
Fusari et al 2010 Italy P Yes CT/MRCP Biopsy (33), histology (7)
Gebel et al 1985 Germany P No US/ERP Obduction (NA), Surgery (NA), FU (NA)
Giovannini et al 1994 France P No EUS ERCP (all)
Glasbrenner et al 2000 Germany P Yes EUS/ERCP Surgery (all)
Gmelin et al 1981 Germany P No US/CT/ERCP Surgery (NA)+FU (NA)
Hellerhoff et al 2002 Germany P Yes MRCP/sMRCP ERCP (35), surgery (4), FU (56)
Imdahl et al 1999 Germany P Yes CT Histology (42), FU (6)
Kremer et al 1977 Germany R No US Clinical diagnosis (338), ERCP, surgery,
ePFT, angiography (NA)
Lammer et al 1980 Germany R No ERCP/CT Surgery (31), angiography (16),
clinical diagnosis (60)
Lawson et al 1978 USA R Yes ERCP/US Surgery (25), FU (50)
Lees et al 1979 UK P No US Surgery (36), ERCP (46)
Lin et al 1989 Taiwan R No US/EUS Histology (26), CT (4), surgery+ERCP (3)
Nattermann et al 1993 Germany P No EUS ERCP (94), FU (20)
Pamos et al 1998 Spain P Yes MRCP ERCP (all)
Parsi et al 2008 USA R Yes ERCP FU (all)
Pistolesi et al 1981 Italy P No CT Surgery (all)
Pungpapong et al 2007 USA P Yes EUS Clinical history, lab data, ERCP/CT/MRI
and/or surgical pathology (all)
Pungpapong et al 2007 USA P Yes MRCP/EUS ERCP (48), surgery (9), FU (57)
Rudowicz-Pietruszewska et al 2002 Poland P No MRCP ERCP (all)
Sai et al 2008 Japan P Yes sMRCP ERCP (all)
Savarino et al 1980 Italy R No CT Surgery (NA), calcifications (NA), clinical and lab data (NA)
Scarabino et al 1989 Italy R No ERCP, US, CT Combination of CT, US and ERCP (all)
Schlaudraff et al 2008 USA and Germany P Yes MRCP/sMRCP Clinical history, laboratory, radiology (≥2 methods) (all)
Stevens et al 2009 USA P Yes EUS ePFT (all)
Sverko et al 2011 Croatia R No MRCP Histology (all)
Swobodnik et al 1983 Germany P No US/CT/ERCP FU (59), surgery (22)
Tox et al 2007 Germany R Yes EUS Surgery (79), FU (92)
Trikudanathan et al 2016 USA R YES EUS Histology (all)
Triller et al 1975 Switzerland P No ERCP Surgery (14), autopsy (1), FU (9)
Wiersema et al 1993 USA P No EUS/ERCP FU (51), ePFT (16)
Zhang et al 2003 USA R No MRCP US (12), CT (11), ERCP (6)
Zuccaro et al 2009 USA R No MRCP/sMRCP ePFT (all)
P prospective, R retrospective, OE observer experience reported, PTC percutaneous transhepatic cholangiogram, ePFT endoscopic pancreatic function
test, FU follow-up, NA not available
Eur Radiol
sensitivity and specificity with 95% CIs. Forest plots were
made to visualize the sensitivity and specificity with the
95% CIs. Summary estimates of sensitivity and specificity,
including 95% CI, were obtained by using a random-effects
model [12]. In cases where a negative covariance between the
logit sensitivity and logit specificity was obtained, summary
receiver operating characteristic curve (sROC) were generated
for each separate imaging modality. We used the z test to
Table 2 Patient characteristics of included studies
Study Nr pts Age Male (%) Nr pts CP Patient selection
Adamek et al 124 55 61% 57 Suspected pancreatic mass (clinical presentation, lab, US)
Albashir et al 23 43* 57% 19 Suspected chronic pancreatitis (clinical presentation)
Alcaraz et al 81 65** 31% 8 Suspected pancreatobiliary disease (clinical presentation, US)
Balci et al 30 48* 17% 11 Suspected early CP (clinical presentation)
Bolog et al 103 57* 43% 15 Suspected pancreatobiliary disease (US/CT or clinical presentation)
Brand et al 115 61* 59% 24 Suspected focal pancreatic lesion (US/CT/ERCP or lab/tumour
markers)
Buscail et al 62 50* 79% 44 Suspected chronic pancreatitis (clinical presentation,
lab, imaging)
Catalano et al 80 51* 40% 38 Non-alcoholic recurrent acute pancreatitis (3–11 episodes)
Chong et al 71 45* 46% 64 Suspected chronic pancreatitis (clinical presentation)
Conwell et al 56 44* 45% 38 Suspected chronic pancreatitis (clinical presentation)
Dramaix et al 50 52* 66% 18 Suspected pancreatic disease (clinical presentation)
Fusari et al 40 62* 55% 8 Suspected pancreatic mass (clinical presentation and US)
Gebel et al US: 56, ERP: 45 NA NA US: 22, ERP: 16 Suspected pancreatic disease (clinical presentation)
Giovannini et al 26 NA NA 17 Suspected pancreatobiliary disease (clinical
presentation, imaging/lab)
Glasbrenner et al 85 NA NA 41 Suspected pancreatic mass (clinical presentation, US/CT)
Gmelin et al 41 54* 68% 19 Suspected pancreatic disease (clinical presentation)
Hellerhoff et al 95 NA NA 26 Suspected pancreatic disease (clinical presentation)
Imdahl et al 48 58* 60% 12 Suspected pancreatic disease (clinical presentation)
Kremer et al 446 NA NA 61 Suspected pancreatic disease (clinical presentation)
Lammer et al 107 NA NA 39 Suspected pancreatic disease (clinical presentation)
Lawson et al 75 NA NA 26 Suspected pancreatic disease (clinical presentation)
Lees et al 98 NA NA 20 Suspected pancreatic disease (clinical presentation)
Lin et al 33 47* 58% 7 Suspected pancreatic disease (clinical presentation)
Nattermann et al 114 53* 67% 51 Suspected pancreatic disease (clinical presentation)
Pamos et al 41 64* 59% 5 Suspected pancreatobiliary disease (clinical presentation)
Parsi et al 35 46** 46% 24 Suspected chronic pancreatitis (clinical presentation)
Pistolesi et al 100 NA NA 31 Suspected pancreatic disease (clinical presentation)
Pungpapong et al 79 50** 35% 38 Suspected chronic pancreatitis (clinical presentation)
Pungpapong et al 99 55** 41% 40 Suspected chronic pancreatitis (clinical presentation)
Rudowicz-Pietruszewska et al 88 52* 64% 9 Suspected pancreatobiliary disease (clinical presentation,
lab, US/CT)
Sai et al 28 36* NA 16 Mild chronic pancreatitis (ERCP)
Savarino et al 108 47** 67% 59 Suspected pancreatic disease (clinical presentation)
Scarabino et al 63 44** 63% 12 Suspected of biliopancreatic disease (clinical presentation)
Schlaudraff et al 62 NA NA 9 Suspected chronic pancreatitis (clinical presentation)
Stevens et al 100 NA 38% 41 Suspected chronic pancreatitis (clinical presentation)
Sverko et al 29 44** 52% 14 Suspected pancreatic disease (clinical presentation)
Swobodnik et al 81 49* 52% 27 Suspected pancreatic disease (clinical presentation)
Tox et al 171 61* NA 65 Suspected pancreatic disease (clinical presentation)
Trikudanathan et al 68 39* 18% 56 Total pancreatectomy for non-calcific chronic pancreatitis
Triller et al 24 52* 83% 11 Suspected pancreatobiliary disease (clinical presentation)
Wiersema et al 67 45* 20% 30 Suspected pancreatobiliary disease (clinical presentation)
Zhang et al 44 50* 30% 24 Suspected early or mild chronic pancreatitis (clinical
presentation, US/CT/ERCP)





evaluate differences in sensitivity and specificity between the
five imaging modalities. A p value of less than 0.05 indicated
a statistically significant difference.
Heterogeneity exploration
The following factors were incorporated in the bivariate mod-
el and we evaluated the effect on the sensitivity and specific-
ity, and cause of heterogeneity for all imaging modalities ac-
cording to the QUADAS-2 tool: clear description of criteria
for bias (low bias versus high bias or unclear) for (a) patient
selection, (b) criteria for the index test used, (c) sufficient
description and verification with the reference standard, and
(d) the flow and timing.
Head to head comparison
A head to head comparison was performed in studies that
compared the diagnostic accuracy of two or more imaging
modalities. Heterogeneity was quantified by I2 test, with
95% CI. The random-effects (I2 > 25%) and fixed effects (I2
≤ 25%) models were used to obtain summary estimates of
sensitivity and specificity, and compared with one another
by a paired z test.
For data analysis, Review Manager (RevMan, version 5.3.
Copenhagen: The Cochrane Collaboration, 2014) and SAS
(version 9.3; SAS Institute, Cary, NC) were used. We adhered
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [13].
Results
Study selection
The initial search resulted in 11,111 hits, of which 2988 du-
plicates were removed, resulting in a total of 8123 titles and
abstracts that were screened for eligibility. The full text of 277
articles was retrieved; 43 of these articles fulfilled the inclu-
sion criteria. See Appendix Table 6 for the excluded articles.
Figure 1 shows the flow chart of the search.
Study and patient characteristics
Study characteristics, including the reference standard for the
diagnosis of CP for each included study, are listed in Table 1.
The 43 included studies were published between 1975 and
2016; 26 studies were prospective and 23 studies were pub-
lished after the year 2000. A total of 3460 patients were eval-
uated, of which 1242 patients were diagnosed with CP
[14–56]. The age of the patients ranged from 36 to 65 years,
with a median of 50% male. Criteria for selection of patients
were those with suspected pancreatic disease or patients with
suspected CP. Patient characteristics are depicted in Table 2.
The risk of bias, assessed by QUADAS-2, was low in 28%
of the studies and high in 19% of the studies. The concerns
about applicability were low in 30% of the studies and high in
40% of the studies. The QUADAS-2 characteristics for each
domain are depicted in Fig. 2 and outlined for each study in
Appendix Table 7. The quality of evidence for all five imaging
modalities according to the GRADE scoring system was very





Proportion of studies with low, high or unclear
RISK of BIAS 
0% 20% 40% 60% 80% 100%
Proportion of studies with low, high, or unclear
CONCERNS regarding APPLICABILITY
Low High Unclear
Fig. 2 Summary of study quality
(QUADAS-2)




Modality N studies N patients Sensitivity (95% CI) Specificity (95% CI) Heterogeneity (I2)
EUS 16 1249 81% (70–89%) 90% (82–95%) 82%/73%
ERCP 11 742 82% (76–87%) 94% (87–98%) 39%/67%
MRCP 14 933 78% (69–85%) 96% (90–98%) 59%/65%
CT 10 700 75% (66–83%) 91% (81–96%) 50%/71%
US 10 1005 67% (53–78%) 98% (89–100%) 40%/93%
Random effects model
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Forest plot: EUS 
Forest plot: ERCP 
Forest plot: MRCP 
Forest plot CT
Forest plot: US 
Fig. 3 Forest plot for sensitivity and specificity
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low. The GRADE scores for each imaging modality and char-
acteristics for each study are outlined in Appendix Tables 8
and 9.
EUS was the most frequently evaluated imaging modality;
16 studies including 1249 patients [15, 19–23, 27, 28, 36, 37,
41, 42, 48, 51, 53, 56]. ERCP was studied in 11 studies in-
cluding 742 patients [14, 20, 26, 28, 29, 33, 34, 39, 46, 50,
52]; MRCP, including secretin-enhanced MRCP, was evaluat-
ed in 14 studies including 933 patients [14, 16–18, 25, 30, 38,
42–44, 47, 49, 54, 55]; CT in 10 studies including 700 patients
[20, 24, 25, 29, 31, 33, 40, 45, 46, 50] and abdominal US in 10
studies which included 1005 patients [20, 24, 26, 29, 32,
34–36, 46, 50]. The imaging characteristics for each study
and modality in an individual study are listed in Appendix
Table 11. Three of the 43 articles reported about complications
of the imaging modality used; these were complications relat-
ed to ERCP (being post-ERCP pancreatitis) with a mean com-
plication rate of 4% [14, 20, 28].
Overall diagnostic accuracy
Analyses for summary estimates of sensitivity and specificity
were done for EUS, ERCP, MRI, CT and US (Table 3).
Figures 3 and 4 show sensitivity and specificity of individual
studies in forest plots and in receiver operator curves (ROC),
respectively. A negative covariance between the logit sensi-
tivity and logit specificity was not obtained; therefore, no
sROC for MRI and US could be drawn. The summary esti-
mate of sensitivity for EUS, ERCP, MRCP, CT and US was
81%, 82%, 78%, 75% and 67%, respectively. The summary
estimate of specificity for EUS, ERCP, MRCP, CT and US
was 90%, 94%, 96%, 91% and 98%, respectively.
Sensitivity of ERCP was significant higher than sensitivity
of US (p = 0.018). Other pairwise comparisons of sensitivity
between imaging modalities revealed no significant diffe-
rence. Specificity did not differ significantly among all
modalities (Table 3). Sensitivity and specificity values for
each study are listed in Appendix Table 10.
Heterogeneity exploration
The bivariate model for heterogeneity exploration showed that
the factor ‘flow and timing’ was significantly associated with
a higher sensitivity of US (p = 0.01). ‘Description and verifi-
cation with the reference standard’ was significantly associat-
ed with a higher specificity for MRCP (p = 0.0002).
Head to head comparison
Six head to head comparisons were performed (Table 4). The
specificity of ERCP and EUS, and the sensitivity of ERCP,
EUS and CT in the summary estimates of the head to head
studies were significantly higher as compared with US.
The head to head comparison of US versus ERCP compar-
ison yields a sensitivity of 57% (49–65%) versus 78% (71–




Fig. 4 Receiver operator curves (ROC)
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98% (89–100%) (p = 0.003), respectively [20, 26, 29, 34, 46,
50]. The comparison between US and CT yields a sensitivity
of 58% (49–66%) and 77% (68–83%) (p = 0.002), respective-
ly [20, 24, 29, 46, 50]. And finally, the comparison of EUS
versus US comparison yields a sensitivity of 90% (82–98%)
versus 63% (49–76%) (p = 0.001); and a specificity of 100%
versus 91% (82–99%) (p = 0.04), respectively [20, 36]. There
were no significant differences in the sensitivity and specific-
ity estimates between ERCP and EUS [20, 28, 53], MRCP
and sMRCP [30, 47, 55] or ERCP and CT [20, 29, 33, 46, 50].
The heterogeneity (I2) between US and ERCP (>25%) was
higher (>25%) than in the other comparisons (I2 ≤ 25%).
Discussion
EUS, ERCP,MRI and CTall have comparable high diagnostic
accuracy in the initial diagnosis of chronic pancreatitis. EUS
and ERCP are outperformers and US has the lowest accuracy.
The choice of imaging modality can therefore be made on the
basis of invasiveness, local availability, experience and costs.
Several recent guidelines [57–59] advocate the use of EUS,
MRCP or CT for the diagnosis of CP, although summary
estimates of their accuracy, thus far, were lacking. There is
one guideline from Germany on CP that has reported sensi-
tivity and specificity regarding EUS, ERCP, MRCP and US,
although not for CT [60]. In this guideline 14 studies were
selected, reporting ranges rather than pooling the data on sen-
sitivity and specificity estimates. This method resulted in re-
sults slightly different from those in the present meta-analyses.
For example the guideline reports a sensitivity of 70–80% for
ERCP and 88% for MRI versus summary estimates of 82%
and 78%, respectively, in the present meta-analyses. The
European Society of Radiology (ESR) is developing the
ESR iGuide, a clinical decision support system for European
imaging referral guidelines, covering various clinical scenari-
os, indications and recommendations (www.esriguide.org)
[61–63]. The results from the present systematic review may
be useful to incorporate in that system.
We excluded three studies where sensitivity and specificity
data were provided, but it was not possible to extract sufficient
data to produce 2 × 2 tables and calculate the diagnostic ac-
curacy values, because only the sensitivity and specificity es-
timates were given [64–66]. In the study by Wang et al., esti-
mates of sensitivity and specificity for EUS, ERCP and US
were in line with the present results; the sensitivity of MR
imaging and CT, however, were much lower (66% and
61%) [66]. The studies by Clave et al. and Orti et al. showed
a lower sensitivity of ERCP (62% and 70%, respectively)
compared to present results (82%) [64, 65].
The risk of missing important studies was minimized by
performing a search in four major databases by two reviewers
independently, without setting any restrictions for language
and publication date. However, this systematic review has
some limitations. The heterogeneity of the pooled studies
was moderate to high in all analyses (between 39% and
93%). However, in the head to head comparison analyses,
the heterogeneity was low in most comparisons (<25%).
Furthermore, the heterogeneity of the reference standards used
in the studies could have influenced individual study results.
Surgery, histology and long-term follow-up of patients are
reliable methods. Some reference standards, such as the use
of endoscopic pancreatic function test (ePFT) for establishing
the diagnosis of CP, could have resulted in under- or
Table 4 Head to head
comparison Comparison N studies N patients Modality Sensitivity (95% CI) Specificity (95% CI)
US vs ERCPa 6 423 US 57% (49–65%) 94% (74–99%)
ERCP 78% (71–85%) 98% (89–100%)
US vs CTb 5 297 US 58% (49–66%) 77% (71–83%)
CT 77% (68–83%) 82% (74–88%)
CT vs ERCPb 5 354 CT 75% (67–82%) 86% (81–90%)
ERCP 84% (77–89%) 90% (85–93%)
EUS vs ERCPb 3 214 EUS 88% (80–93%) 85% (76–91%)
ERCP 86% (78–91%) 92% (85–96%)
MRCP vs sMRCPb 3 226 MRCP 62% (49–73%) 94% (89–97%)
sMRCP 68% (56–79%) 91% (85–94%)
EUS vs USb 2 95 EUS 90% (82–98%) 100%
US 63% (49–76%) 91% (82–99%)
Sensitivity: US vs ERCP (p < 0.001), US vs CT (p = 0.002), EUS vs US (p = 0.001)
Specificity: US vs ERCP (p = 0.003), EUS vs US (p = 0.04)
a Random effects model
b Fixed effects model
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overestimation of the sensitivity and specificity. In addition,
the diagnosis of CP and the criteria used are different in dif-
ferent stages of the disease (e.g. absence of calcifications in
the early phase of the disease). Another limitation was that our
analyses included imaging studies and imaging protocols per-
formed over the last 40 years in different centres with inherent
variations in techniques and equipment. Especially in the last
decade the quality of some imaging modalities (e.g. MRCP
and CT) has improved considerably. Also there were concerns
about the quality of the available evidence, as assessed by
QUADAS-2 and the GRADE scoring system.
The highest scores for accuracy in the diagnosis of CPwere
found for EUS and ERCP, but these are invasive techniques.
ERCP has a relatively high risk of complications, such as post-
ERCP pancreatitis (1.6–15.7%, mean complication rate of
4%) and is nowadays only used for therapeutic purposes
(e.g. stenting of pancreatic duct) [67–69]. To date, diagnostic
ERCP is largely replaced by EUS and the cross-sectional im-
aging modalities CT and MRCP.
It has been suggested that CT is better in detecting paren-
chymal calcifications and intraductal calcifications compared
to MRCP [70–73]. On the other hand, MRCP is more often
able to detect significant abnormalities of the pancreatic duct
(e.g. PD dilatation and strictures) and slight changes of the
pancreatic parenchyma and side branches, which can be at-
tributed to early signs CP (i.e. atrophy, side branch ectasia)
compared to CT [74]. Early diagnosis can also lead to a timely
start of treatment, which has been associated with improved
long-term outcome [75]. Nevertheless, for very early CP this
association needs to be established in further research, such as
the ESCAPE trial, evaluating the effect of early intervention in
patients with CP [76]. As diagnostic sensitivity of CT and
MRCP is not significantly lower than that of ERCP and
EUS, and specificity is comparable, non-invasive modalities
except for US are a likely first choice in patients with
suspected pancreatic disease including chronic pancreatitis.
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Table 5 Search terms
MeSH terms All Fields
Chronic
pancreatitis
Pancreatitis, chronic [MeSH] Chronic pancreatitis [All Fields]
AND





[All Fields] OR ERCP [All Fields]
OR




Magnetic resonance imaging [All Fields]
OR MRI [All Fields] OR MRCP [All Fields]
OR Magnetic Resonance Cholangio* [All
Fields]
OR
sMRCP Magnetic Resonance Imaging [All Fields]
AND secretin [All Fields] OR sMRI [All Fields]
OR
CT Tomography, X-Ray Computed [MeSH] (Tomography [All Fields] AND x-ray
[All Fields] AND computed [All Fields])
OR Computed Tomography [All Fields])
OR CT scan* [All Fields]
OR





Table 6 Excluded articles based
on full text Author Year Journal Reason for exclusion
Borsukov et al 2001 Ross Gastroenterol Zh Article not available
Diad'kin et al 2013 Vestnik rentgenologii i radiologii Article not available
Dotsenko et al 1985 Vrach Delo Article not available
Rosch et al 1989 Z Gastroenterologie Article not available
Suzdalev et al 1992 Likars'ka sprava Article not available
Agarwal et al 2008 GIE Exclusive patient group
Brailski et al 1989 Vutr Boles Exclusive patient group
Brailski et al 1984 Vutr Boles Exclusive patient group
Brimiene et al 2011 Medicina Exclusive patient group
Carlucci et al 1989 HPB Surgery Exclusive patient group
Chowdhury et al 2005 Pancreas Exclusive patient group
Cotton et al 1980 Radiology Exclusive patient group
DelMaschio et al 1991 Radiology Exclusive patient group
Erturk et al 2006 Am J Gastroenterol Exclusive patient group
Frick et al 1982 Gastrointest Rad Exclusive patient group
Gheonea et al 2013 BMC Gastroenterology Exclusive patient group
Goodale et al 1981 Ann Surg Exclusive patient group
Hanninen et al 2002 Radiology Exclusive patient group
Hatano et al 1998 Nippon rinsho J Exclusive patient group
Hocke et al 2008 Dtsch Med Wochenschr Exclusive patient group
Hocke et al 2006 WJG Exclusive patient group
Hocke et al 2012 Z Gastroenterologie Exclusive patient group
Huang et al 2011 J Dig dis Exclusive patient group
Imbriaco et al 2006 Radiol Med Exclusive patient group
Kawai et al 2012 Eur J Rad Exclusive patient group
Kim et al 2007 J MRI Exclusive patient group
Kursawa et al 1991 Radiol Diagn Exclusive patient group
Lu et al 2013 Acad J Sec Mil Med University Exclusive patient group
Lutz et al 1975 Klin Wschr Exclusive patient group
Morris-Stiff et al 2009 J Pancreas Exclusive patient group
Papp et al 1978 Wiener klin Wchnschrft Exclusive patient group
Pomerri et al 1991 Radiologia Med Exclusive patient group
Rosch et al 2000 Am J Gastroenterol Exclusive patient group
Sandrasegaran et al 2013 AJR Exclusive patient group
Sendler et al 2000 World J Surg Exclusive patient group
Sugumar et al 2011 Gut Exclusive patient group
Testoni et al 1981 Acta Endoscopica Exclusive patient group
Tiushin et al 2003 Voprosy onkologii Exclusive patient group
Varadarajulu et al 2007 GIE Exclusive patient group
Viceconte et al 1980 Ann ital chir Exclusive patient group
Yamada et al 2010 Abdom Imaging Exclusive patient group
Zhu et al 2013 PLOS one Exclusive patient group
Bhutani et al 2009 Pancreas In vitro
Akisik et al 2013 AJR No diagnostic values for CP
Alempijević et al 2005 Vojnosanit Pregl No diagnostic values for CP
Alpern et al 1985 Radiology No diagnostic values for CP
Ardelean et al 2014 Med Ultrason No diagnostic values for CP
Ardengh et al 2011 GIE No diagnostic values for CP
Ascunce et al 2010 Surg End No diagnostic values for CP
Baert et al 1977 Radiologe No diagnostic values for CP
Balci et al 2010 J MRI No diagnostic values for CP
Beliao et al 2012 Eur J Rad No diagnostic values for CP
Bender et al 1999 Invest Rad No diagnostic values for CP
Bhatt et al 2005 Indian J Rad Imag Ass No diagnostic values for CP
Bonanno et al 1994 Giorn Ital End Dig No diagnostic values for CP
Bruhlmann et al 1976 RoFo No diagnostic values for CP
Caletti et al 1982 British j Surgery No diagnostic values for CP
Cao 1989 Zhonghua yi xue za zhi No diagnostic values for CP
Cappeliez et al 2000 Radiology No diagnostic values for CP
Chang et al 2010 GIE No diagnostic values for CP
Eur Radiol
Table 6 (continued)
Author Year Journal Reason for exclusion
Cohen et al 2014 Dig Dis Sci No diagnostic values for CP
Concia et al 2014 Invest Rad No diagnostic values for CP
Dale et al 1979 Electromedica No diagnostic values for CP
Das et al 2008 GIE No diagnostic values for CP
Delbeke et al 1999 J Nucl Med No diagnostic values for CP
Dite et al 1982 Vnitrni Lekarstvi No diagnostic values for CP
Dronamraju et al 2016 Ann Gastroenterol No diagnostic values for CP
D’Souza et al 2015 Dig Dis Sci No diagnostic values for CP
Eitner et al 1979 Dtsch Zeitschr Verdauungs- und
Stoffwechselkrankheiten
No diagnostic values for CP
Eloubeidi et al 2013 Pancreas No diagnostic values for CP
Ergul et al 2014 Rev Esp Med Nucl Im Mol No diagnostic values for CP
Ferrucci et al 1979 Radiology No diagnostic values for CP
Foley et al 1980 Gastrointest Rad No diagnostic values for CP
Fontana et al 1976 Gut No diagnostic values for CP
Foster et al 1984 BMJ No diagnostic values for CP
Gardner et al 2014 Pancreas No diagnostic values for CP
Gincul et al 2014 Endoscopy No diagnostic values for CP
Gowland et al 1981 Lancet No diagnostic values for CP
Grant et al 1981 J Am Osteopathic Ass No diagnostic values for CP
Harada et al 1977 Gastroenterologica Jap No diagnostic values for CP
He et al 2014 Pancreas No diagnostic values for CP
Hoki et al 2009 J Gastroenterol No diagnostic values for CP
Hollerbach et al 1994 Med Klinik No diagnostic values for CP
Horii et al 1982 Jap J Gastroenterol No diagnostic values for CP
Johnson et al 1999 Radiology No diagnostic values for CP
Jones et al 1988 Clin Radiol No diagnostic values for CP
Kamisawa et al 2007 J Gastroenterol No diagnostic values for CP
Kersting et al 2009 Gastroenterology No diagnostic values for CP
Kitano et al 2004 Gut No diagnostic values for CP
Laghi et al 1998 Chirurgia No diagnostic values for CP
Leblanc et al 2014 Pancreas No diagnostic values for CP
Leblanc et al 2014 Pancreas No diagnostic values for CP
Li et al 2001 Zhongguo yi xue ke xue No diagnostic values for CP
Loginov et al 1976 Sovetskaya Meditsina No diagnostic values for CP
Lopez et al 2002 Radiology No diagnostic values for CP
Manfredi 2000 Radiology No diagnostic values for CP
Modder et al 1979 RoFo No diagnostic values for CP
Montori et al 1979 Min Diet Gastroent No diagnostic values for CP
Napoleon et al 2010 Endoscopy No diagnostic values for CP
Novis et al 1976 S Afr Med J No diagnostic values for CP
Ohtsubo et al 2008 Gastroenterolog Endoscopy No diagnostic values for CP
Orlikov et al 2007 Ter Arkh No diagnostic values for CP
Park et al 2008 The Korean J Gastroenter No diagnostic values for CP
Petersein et al 2002 RoFo No diagnostic values for CP
Pezzelli et al 2013 Pancreas No diagnostic values for CP
Pomerri et al 1987 Radiologia Med No diagnostic values for CP
Rickes et al 2002 Scand J Gastroenterol No diagnostic values for CP
Rosenberger et al 1979 MMW No diagnostic values for CP
Russell et al 1978 Gut No diagnostic values for CP
Sahai et al 1998 GIE No diagnostic values for CP
Sainani et al 2009 AJG No diagnostic values for CP
Sica et al 2002 J MRI No diagnostic values for CP
Sica et al 1999 Radiology No diagnostic values for CP
Songur et al 2000 Digest Endoscopy No diagnostic values for CP
Stevens et al 2010 WJG No diagnostic values for CP
Struve et al 1982 Diagnostik & Intensivtherapie No diagnostic values for CP
Sun et al 2010 Acad J Sec Mil Med University No diagnostic values for CP
Tamura et al 2006 Radiology No diagnostic values for CP
Tellez-Avila et al 2014 WJG No diagnostic values for CP
Eur Radiol
Table 6 (continued)
Author Year Journal Reason for exclusion
Tirkes et al 2016 J MRI No diagnostic values for CP
Trikudanathan et al 2015 Am J Gastroenterol No diagnostic values for CP
Tripathi et al 2002 Indian J Gastroenterol No diagnostic values for CP
Tympner et al 1979 Leber Magen Darm No diagnostic values for CP
Tympner et al 1977 Verhand Dtschen Gesellschaft fur Innere
Medizin
No diagnostic values for CP
Uskudar et al 2009 Pancreas No diagnostic values for CP
Valentini et al 1981 Endoscopy No diagnostic values for CP
Varghese et al 2002 Clin Radiol No diagnostic values for CP
Wang et al 2013 WJG No diagnostic values for CP
Wierzbicka-Paczos
et al
1998 Gastroenterologia Polska No diagnostic values for CP
Wierzbicka-Paczos
et al
1999 Polski Merk Lek No diagnostic values for CP
Will et al 2010 Ultraschall Med No diagnostic values for CP
Zaheer et al 2014 Eur J Rad No diagnostic values for CP
Bian et al 2014 Chin J Radiol No reference standard
Braganza et al 1978 Clin Radiol No reference standard
Gillams et al 2007 Eur J Rad No reference standard
Helmberger et al 2000 RoFo No reference standard
Hernandez Garces
et al
2004 J Pancreas No reference standard
Ho et al 2006 Clin Gastroenterol Hep No reference standard
Kalmar et al 1984 Southern Medical J No reference standard
Kalmin et al 2011 Can J Gastroenterol No reference standard
Kaufman et al 1989 GIE No reference standard
Kumon et al 2012 GIE No reference standard
Manfredi et al 1998 La Rad Medica No reference standard
Novotny et al 2000 Bratisl Lek Listy No reference standard
Ponette et al 1976 Acta Gastro-Enterol Belgica No reference standard
Sanyal et al 2012 AJR No reference standard
Yoshimoto et al 1980 Jap J Gastroenterol No reference standard
Grossjohann et al 2010 Scand J Gastroenterol Not enough patients
Sood et al 1992 Indian J Gastroenterol Not enough patients
Zhi et al 2002 Chin J Digestive Dis Not enough patients
Zhong et al 2003 WJG Not enough patients
Ainsworth et al 2003 Endoscopy Only sensitivity reported
Bastid et al 1995 J d'Echographie et de Med par Ultrasons Only sensitivity reported
Campisi et al 2009 Clin Radiol Only sensitivity reported
Dancygier et al 1986 Scand J Gastroenterol Only sensitivity reported
Giday et al 2011 J Gastr Hep Only sensitivity reported
Guarita et al 1982 AMB Only sensitivity reported
Guo et al 2003 Chin J Digestive Dis Only sensitivity reported
Kahl et al 2002 GIE Only sensitivity reported
Kim et al 2001 AJR Only sensitivity reported
Kolmannskog et al 1981 Acta Radiologica Only sensitivity reported
Lackner et al 1980 RoFo Only sensitivity reported
Lawson 1978 Radiology Only sensitivity reported
Manfredi 2002 Radiology Only sensitivity reported
Mao et al 2011 WCJD Only sensitivity reported
Nakashio 1992 Acta medica Only sensitivity reported
Noguchi et al 1985 Gastroenterolog Endoscopy Only sensitivity reported
Propp 2011 Vestnik khirurgii imeni Only sensitivity reported
Rossi et al 1996 Giorn Ital End Dig Only sensitivity reported
Sahel et al 1976 Acta Endoscopica Only sensitivity reported
Seicean et al 2010 Ultraschall Med Only sensitivity reported
Sildiroglu 1985 Rontgenpraxis Only sensitivity reported
Singh et al 1993 Indian J Rad Imag Only sensitivity reported
Sivak et al 1986 Scand J Gastroenterol Only sensitivity reported
Stabile Ianora et al 2013 Recenti Prog Med Only sensitivity reported
Stevens et al 2008 Dig Dis Sci Only sensitivity reported
Eur Radiol
Table 6 (continued)
Author Year Journal Reason for exclusion
Stevens et al 2010 Dig Dis Sci Only sensitivity reported
Triller et al 1983 Computertomographie Only sensitivity reported
Uchida et al 1997 Jap J Clin Radiology Only sensitivity reported
Vitale et al 2009 The Am Surgeon Only sensitivity reported
Wang et al 2009 J Gastr Hep Only sensitivity reported
Wu et al 2006 World Chin J Dig Only sensitivity reported
Yanling et al 2001 Chinese J Gastroenterol Only sensitivity reported
Zhou et al 1993 Zhonghua nei ke za zhi Only sensitivity reported
Aithal et al 2002 GIE Other disease
Doust et al 1976 Radiology Other disease
Engjom et al 2015 Scan J Gastroenterol Other disease
Huang et al 2009 Acad J Sec Mil Med University Other disease
Kushnir et al 2011 GIE Other disease
Lai et al 2004 Endoscopy Other disease
Leblanc et al 2014 Pancreas Other disease
Matos et al 2001 GIE Other disease
Mosler et al 2012 Dig Dis Sci Other disease
Novis et al 2010 Rev Colegio Brasileiro Cirurg Other disease
Rana et al 2012 J Gastr Hep Other disease
Ranney et al 2012 GIE Other disease
Sainani et al 2015 Pancreas Other disease
Soto et al 2005 Radiology Other disease
Akisik et al 2009 Radiology Other imaging modality
Cherian et al 2010 HPB Surgery Other imaging modality
Glaser et al 1994 Int J Pancreatology Other imaging modality
Glaser et al 1989 Scand J Gastroenterol Other imaging modality
Glaser et al 1985 Ultraschall Med Other imaging modality
Hocke et al 2007 Pancreas Other imaging modality
Kumon et al 2010 GIE Other imaging modality
Saftoiu et al 2008 GIE Other imaging modality
Sreenarasimhaiah 2008 J Clin Gastroenterol Other imaging modality
Tummula et al 2013 Clin Transl Gastroenterol Other imaging modality
Uehara et al 2011 J Gastr Hep Other imaging modality
Abdalla et al 2012 Gastroenterolgy Other type of article
Arsac et al 1981 Med Chirurgie Digest Other type of article
Ashida et al 2011 J Gastr Hep Other type of article
Chvatalova et al 2012 Pancreatology Other type of article
Czako et al 2007 J Gastroenterol Other type of article
Gupta et al 2013 JIMSA Other type of article
Heverhagen et al 2007 RoFo Other type of article
Kasugai et al 1982 Stomach and intestine Other type of article
Kent et al 2008 Pancreas Other type of article
Markwardt et al 1980 Radiologia Diagn Other type of article
Munoz et al 2010 Rev Med de Chile Other type of article
Musunuri et al 2015 Ind J Gastroenterol Other type of article
Quinn et al 2012 Gut Other type of article
Romagnuolo et al 2012 GIE Other type of article
Sherman et al 2012 GIE Other type of article
Shibukawa et al 2015 Dig Endos Other type of article
Stevens et al 2008 Pancreas Other type of article
Takahashi et al 2014 AJR Other type of article
Trus et al 1998 Probl Gen Surg Other type of article
Vadrot et al 1981 Med Chirurgie Digest Other type of article
Zaruba et al 2012 Pancreatology Other type of article
Zhang et al 2011 J Gastr Hep Other type of article
Eur Radiol
Table 7 QUADAS-2 characteristics for each study
Study Bias Applicability
Patient selection Index test Reference standard Flow and timing Patient selection Index test Reference standard
Adamek et al Low Low Low Low Unclear Unclear Low
Albashir et al Low Low Low Low Low Low Low
Alcaraz et al Low Low Low Low High Unclear Low
Balci et al Low Low Unclear Low Low Low Unclear
Bolog et al Low Unclear Low Low High Unclear Low
Brand et al Low Low Low High High Low Low
Buscail et al Low Unclear Low Low High Unclear Low
Catalano et al Unclear Low Unclear Low Low Low Low
Chong et al Low Low Low Low Low Low Low
Conwell et al Low Low High Low Low Low Unclear
Dramaix et al Low Low Low Low Low Unclear Low
Fusari et al Unclear Low Low Low High Low Low
Gebel et al Low Low Low High Low Unclear Low
Giovannini et al Unclear Unclear Low Low High Unclear Unclear
Glasbrenner et al Low Low Low Low High Low Low
Gmelin et al Low Low Low Low Low High Unclear
Hellerhoff et al Low Low Low Low Low Low Low
Imdahl et al Low Low Unclear Low Low Unclear Low
Kremer et al High Unclear Unclear High High Unclear Low
Lammer et al Low Low Unclear Low Low Unclear Unclear
Lawson et al Low Low Unclear Low Low Low Unclear
Lees et al Low Low Low High Low High Low
Lin et al High Unclear Low Low Low Unclear Low
Nattermann et al Unclear Low Low Low High Unclear Low
Pamos et al Low Low Low Low High Unclear Low
Parsi et al Low Low Low Low Low Low Low
Pistolesi et al Unclear Low Low Low Low Low Low
Pungpapong et al Low Low Low Low Low Low Low
Pungpapong et al Low Unclear Unclear Low Low Low Low
Rudowicz Pietr-uszewska et al Low Unclear Low Low High Unclear Unclear
Sai et al High Low Low Low Low Low Low
Savarino et al Unclear Low Low Low Low Low Low
Scarabino et al Low Unclear Unclear Low High Unclear Unclear
Schlaudraff et al Low Unclear Low Low Low Low Low
Stevens et al Low Low Unclear Low Low Low Unclear
Sverko et al Unclear Unclear Low Low Low Unclear Low
Swobodnik et al Low Low Low Low Low Low Low
Tox et al Low Unclear Unclear Low Low Low Low
Trikudanathan et al Unclear Low Unclear Low High Low Low
Triller et al Unclear Low Unclear Low Unclear Unclear Low
Wiersema et al Unclear Low Unclear Low High Low Unclear
Zhang et al High Unclear High Low Low Unclear High








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9 GRADE characteristics for each study
Modality Name first author Risk of bias Indirectness Inconsistency Imprecision Publication bias





Brand et al Serious Serious
Buscail et al Serious Serious
Catalano et al Low Low
Chong et al Low Low
Conwell et al Serious Serious
Giovannini et al Serious Serious
Glasbrenner et al Low Low
Lin et al Serious Serious
Nattermann et al Low Serious
Pungpapong et al Low Low
Pungpapong et al Low Low
Stevens et al Serious Serious
Tox et al Serious Low
Trikudanathan et al Serious Serious
Wiersema et al Serious Serious





Buscail et al Low Serious
Gebel et al Low Low
Glasbrenner et al Low Low
Gmelin et al Low Serious
Lammer et al Serious Serious
Lawson et al Low Low
Parsi et al Low Low
Scarabino et al Serious Serious
Swobodnik et al Low Low
Triller et al Serious Serious





Alcaraz et al Low Serious
Balci et al Serious Serious
Bolog et al Serious Serious
Fusari et al Low Low
Hellerhoff et al Low Low
Pamos et al Low Serious
Pungpapong et al Low Low
Rudowicz-Pietruszewska Serious Serious
Sai et al Serious Low
Schlaudraff et al Low Low
Sverko et al Serious Serious
Zhang et al Very serious Serious
Zuccaro et al Serious Serious





Dramaix et al Low Low
Fusari et al Low Low
Gmelin et al Low Serious
Imdahl et al Serious Low
Lammer et al Serious Serious
Pistolesi et al Low Low
Savarino et al Serious Low
Scarabino et al Serious Serious
Swobodnik et al Low Low





Dramaix et al Low Low
Gebel et al Low Low
Gmelin et al Low Serious
Kremer et al Very serious Serious
Lawson et al Low Low
Lees et al Serious Low
Lin et al Serious Serious
Scarabino et al Serious Serious
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